283 related articles for article (PubMed ID: 25486197)
21. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.
Griffiths HBS; Williams C; King SJ; Allison SJ
Biochem Soc Trans; 2020 Jun; 48(3):733-744. PubMed ID: 32573651
[TBL] [Abstract][Full Text] [Related]
22. Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.
Bolandghamat Pour Z; Nourbakhsh M; Mousavizadeh K; Madjd Z; Ghorbanhosseini SS; Abdolvahabi Z; Hesari Z; Ezzati Mobasser S
BMC Cancer; 2019 Nov; 19(1):1027. PubMed ID: 31675930
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex.
Morris-Blanco KC; Cohan CH; Neumann JT; Sick TJ; Perez-Pinzon MA
J Cereb Blood Flow Metab; 2014 Jun; 34(6):1024-32. PubMed ID: 24667915
[TBL] [Abstract][Full Text] [Related]
24. Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers.
Shackelford RE; Bui MM; Coppola D; Hakam A
Int J Clin Exp Pathol; 2010 Jun; 3(5):522-7. PubMed ID: 20606733
[TBL] [Abstract][Full Text] [Related]
25. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression.
Wang YQ; Yan Q; Zhang JR; Li SD; Yang YX; Wan XP
J Obstet Gynaecol Res; 2013 Feb; 39(2):549-54. PubMed ID: 23006047
[TBL] [Abstract][Full Text] [Related]
27. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
[TBL] [Abstract][Full Text] [Related]
28. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
Xiong X; Yu J; Fan R; Zhang C; Xu L; Sun X; Huang Y; Wang Q; Ruan HB; Qian X
PLoS One; 2019; 14(2):e0212523. PubMed ID: 30794635
[TBL] [Abstract][Full Text] [Related]
29. Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.
Oita RC; Camp SM; Ma W; Ceco E; Harbeck M; Singleton P; Messana J; Sun X; Wang T; Garcia JGN
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):36-44. PubMed ID: 29337590
[TBL] [Abstract][Full Text] [Related]
30. Nampt: linking NAD biology, metabolism and cancer.
Garten A; Petzold S; Körner A; Imai S; Kiess W
Trends Endocrinol Metab; 2009 Apr; 20(3):130-8. PubMed ID: 19109034
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-26b Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase in Breast Cancer Cells.
Ameli Mojarad M; Ameli Mojarad M; Pourmahdian A
DNA Cell Biol; 2022 Aug; 41(8):735-741. PubMed ID: 35792597
[TBL] [Abstract][Full Text] [Related]
32. Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
Zhao Y; Guan YF; Zhou XM; Li GQ; Li ZY; Zhou CC; Wang P; Miao CY
Stroke; 2015 Jul; 46(7):1966-74. PubMed ID: 26060246
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ
J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366
[TBL] [Abstract][Full Text] [Related]
34. Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics.
Kamada M; Ikeda K; Manome Y
Anticancer Res; 2020 Sep; 40(9):4895-4905. PubMed ID: 32878777
[TBL] [Abstract][Full Text] [Related]
35. NAMPT-Mediated NAD Biosynthesis as the Internal Timing Mechanism: In NAD+ World, Time Is Running in Its Own Way.
Poljsak B
Rejuvenation Res; 2018 Jun; 21(3):210-224. PubMed ID: 28756747
[TBL] [Abstract][Full Text] [Related]
36. Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism.
Frederick DW; Davis JG; Dávila A; Agarwal B; Michan S; Puchowicz MA; Nakamaru-Ogiso E; Baur JA
J Biol Chem; 2015 Jan; 290(3):1546-58. PubMed ID: 25411251
[TBL] [Abstract][Full Text] [Related]
37. DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming.
Yang X; Wang X; Yang Y; Li Z; Chen Y; Shang S; Wang Y
J Transl Med; 2023 Jul; 21(1):481. PubMed ID: 37464424
[TBL] [Abstract][Full Text] [Related]
38. Loss of NAMPT in aging retinal pigment epithelium reduces NAD
Jadeja RN; Powell FL; Jones MA; Fuller J; Joseph E; Thounaojam MC; Bartoli M; Martin PM
Aging (Albany NY); 2018 Jun; 10(6):1306-1323. PubMed ID: 29905535
[TBL] [Abstract][Full Text] [Related]
39. Depletion of NAD pool contributes to impairment of endothelial progenitor cell mobilization in diabetes.
Wang P; Yang X; Zhang Z; Song J; Guan YF; Zou DJ; Miao CY
Metabolism; 2016 Jun; 65(6):852-62. PubMed ID: 27173464
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
